Follistatin-344
PreclinicalFollistatin-344 (FST-344)
- Category
- Growth Hormone
- Aliases
- FST-344, FS-344
- Administration
- Subcutaneous injection (preclinical/research use)
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
As a preclinical-only compound, there is no established human timeline for felt effects at this stage.
- 2
3–4 Weeks
Animal studies show early signs of muscle fiber growth within a similar timeframe, though this hasn't been confirmed in humans.
- 3
5–7 Weeks
No human data exists to describe a typical experience at this stage.
- 4
8–10 Weeks
No human data exists to describe a typical experience at this stage.
- 5
11–15 Weeks
No human data exists to describe a typical experience at this stage.
- 6
16–20 Weeks
No human data exists to describe a typical experience at this stage.
- 7
21–24 Weeks
No human data exists to describe a typical experience at this stage; real-world human timelines remain unknown.
⚠️ Research context only. This is not medical advice and results are not guaranteed.